Podcasts about treatments

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

Dr. Arthur Burnett called in to discuss erectile dysfunction causes, treatments and more. Tune in to hear all the details including how Dr. Arthur Burnett helped bring Viagra to market, what can causes erectile dysfunction and how it can be physical and/or psychological, how and why ED can be an early warning sign of cardiovascular disease and diabetes, why men shouldn't be embarrassed to talk about it, how testosterone affects libido vs. erections, what Trimix is and when it's used, how lifestyle changes like diet, sleep and weight loss can improve erections, how GLP-1 receptor agonists may impact sexual function, whether you can become dependent on Viagra or Cialis, the side effects of ED meds, all the treatment options from pills to pumps to penile implants and how they work, what a venous leak is and why it's hard to fix, how to know if your ED is normal aging or something more serious plus a whole lot more. Check out his book Manhood Rx GET A COPY OF THE STRICTLY ANONYMOUS BOOK! Strictly Anonymous Confessions: Secret Sex Lives of Total Strangers. A bunch of short, super sexy, TRUE stories. GET YOUR COPY HERE: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://amzn.to/4i7hBCd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To see HOT pics of my female guests + hear anonymous confessions + get all the episodes early and AD FREE, join my Patreon! It's only $7 a month and you can cancel at any time. You can sign up here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/StrictlyAnonymousPodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and when you join, I'll throw in a complimentary link to my private Discord! To join SDC and get a FREE Trial! click here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.sdc.com/?ref=37712⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to SDC.com and use my code 37712   Want to be on the show? Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠strictlyanonymouspodcast@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and click on "Be on the Show." Want to confess while remaining anonymous? Call the CONFESSIONS hotline at 347-420-3579. All voices are changed.   Sponsors: ⁠https://inda.shop/STRICTLY!⁠⁠ If you're 21 or older, get 40% OFF your first order @IndaCloud with code STRICTLY ⁠⁠⁠⁠https://beducate.me/pd2610-anonymous⁠⁠⁠⁠⁠⁠ — Click here to take the quiz and  get your personalized roadmap to sexual happiness ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.quince.com/strictlyanon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ — For premium quality Quince clothing plus FREE shipping and 365 day returns! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bluechew.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ — Get 10% OFF your first month of Bluechew GOLD! Use code: STRICTLYANON⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://LoadBoost.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ — To get 10% off LOAD BOOST by VB Health use code: STRICTLY Follow me! Instagram  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/strictanonymous/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ X  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/strictanonymous?lang=en⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Everything else: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/Strictlyanonymouspodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

With the increasing incidence of colorectal cancer in those less than 50 years of age, one must wonder how many patients present with a Stage IV diagnosis. Take a deep dive with us discussing the management of metastatic colorectal cancer by joining our team and guests, Drs. Cathy Eng, Michael D'Angelica, and Nina Sanford.Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center- Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian- Dr. Philip Bauer, Assistant Professor of Surgery, Division of Colon and Rectal Surgery, The Ohio State University Wexner Medical Center, Arthur G. James Cancer Hospital-  Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Guest Speakers:- Dr. Michael D'Angelica MD, FACS – Hepatopancreatobiliary Surgery, Memorial Sloan Kettering Cancer Center, Enid A. Haupt Chair in Surgery, Vice Chair, Education- Dr. Cathy Eng MD, FACP - Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, David H. Johnson Endowed Chair in Surgical and Medical Oncology, Professor of Medicine, Hematology and Oncology, VICC Associate Director for Strategic Relations and Research Partnerships, Executive Director, Young Adult Cancers Program - Dr. Nina Sanford, MD – Radiation Oncology, UT Southwestern Medical Center, Chief of Gastrointestinal Radiation Oncology Service, Associate Professor Learning Objectives:1.     Review the epidemiology, prognosis, and common metastatic patterns of metastatic colorectal cancer (mCRC).2.     Discuss the role of systemic chemotherapy and targeted therapies in the first- and subsequent-line treatment of mCRC, including the impact of molecular biomarkers such as MSI/MMR, RAS, BRAF, and HER2.3.     Evaluate the indications and timing of surgical and locoregional therapies for metastatic colorectal cancer, particularly in patients with liver-limited or oligometastatic disease.4.     Describe the multidisciplinary management of mCRC, including the roles of radiation therapy, systemic therapy sequencing, and palliative interventions to optimize outcomes and quality of life.References:Singh, M., Morris, V. K., Bandey, I. N., Hong, D. S. & Kopetz, S. Advancements in combining targeted therapy and immunotherapy for colorectal cancer. Trends Cancer 10, 598–609 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38821852/Napolitano, S. et al. BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives. Cancer Treat. Rev. 134, (2025). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40009904/Ciardiello, F. et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA. Cancer J. Clin. 72, 372–401 (2022). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35472088/Kim, S. Y. & Kim, T. W. Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer. ESMO Open 5, e000634 (2020). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/32188714/Biller, L. H. & Schrag, D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA 325, 669–685 (2021). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/33591350/Smith, J. J. et al. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Med. 8, 6538–6548 (2019). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/31503397/Saadat, L. V. et al. Hepatic Artery Infusion Chemotherapy Compared to Transarterial Radioembolization For Unresectable Colorectal Liver Metastases. Ann. Surg. 10.1097/SLA.0000000000006851 doi:10.1097/SLA.0000000000006851. PubMed Link: https://pubmed.ncbi.nlm.nih.gov/?term=10.1097/SLA.0000000000006851 (Linked via DOI search as the direct PMID is still indexing)Xiao, A. & Fakih, M. KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer. Clin. Colorectal Cancer 23, 199–206 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38825433/André, T. et al. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer. N. Engl. J. Med. 383, 2207–2218 (2020). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/33264544/Morris, V. K. et al. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J. Clin. Oncol. 41, 678–700 (2023). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/36252154/Xu, Z. et al. Treatments for Stage IV Colon Cancer and Overall Survival. J. Surg. Res. 242, 47–54 (2019). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/31071604/Smith, J. J. & D'Angelica, M. I. Surgical Management of Hepatic Metastases of Colorectal Cancer. Hematol. Oncol. Clin. North Am. 29, 61–84 (2015). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/25475573/Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/37142372/Kruijssen, D. E. W. van der et al. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group. Ann. Oncol. 35, 769–779 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38852675/Hitchcock, K. E., Romesser, P. B. & Miller, E. D. Local Therapies in Advanced Colorectal Cancer. Hematol. Oncol. Clin. North Am. 36, 553–567 (2022). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35562258/Hitchcock, K. E. et al. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC Cancer 24, 201 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38350888/Adam, R. et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. The Lancet 404, 1107–1118 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/39306468/Elez, E. et al. Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer. N. Engl. J. Med. 392, 2425–2437 (2025). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40444708/***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Host Janet Michael sits down with Dr. Michael Avery, board-certified general surgeon, Colorectal surgery specialist with Valley Health Surgical Oncology at Winchester Medical Center  to discuss colorectal cancer — why awareness matters, who's at risk, how to screen, and how far treatment has come. Dr. Avery brings both personal backstory and clinical expertise to a conversation that could save your life. About Dr. Avery Originally from Charlotte, NC; discovered medicine through a hospital internship Completed undergrad at East Carolina University, medical school at Campbell University General surgery residency at Carolinas Medical Center; colorectal fellowship at UT Southwestern in Dallas Now practicing at Valley Health Surgical Oncology, Winchester Medical Center Colorectal Cancer by the Numbers 3rd most commonly diagnosed cancer in men and women 2nd leading cause of cancer death 150,000+ diagnoses in 2023; approximately 50,000 deaths Nearly half of cases are linked to modifiable risk factors Screening: What You Need to Know Screening should begin at age 45 for average-risk individuals (lowered from 50) If a first-degree relative was diagnosed, begin screening 10 years before their diagnosis age Gold standard: Colonoscopy — both diagnostic and therapeutic in one procedure Alternative options: Cologuard (DNA stool test, ~94–95% sensitivity), CT colonography A positive Cologuard result requires follow-up colonoscopy Colonoscopy prep and sedation have improved significantly — most patients feel comfortable and remember nothing Warning Signs & Symptoms Rectal bleeding (hematochezia) Abdominal pain Changes in bowel habits (constipation or diarrhea) Iron deficiency anemia Unintentional weight loss Blood mixed in stool Note: Do not dismiss these symptoms at any age — young-onset colorectal cancer is rising Risk Factors Non-modifiable: Family history, inflammatory bowel disease, genetics Modifiable: Sedentary lifestyle, obesity, diet high in processed meats/red meats/refined grains/sugar-sweetened beverages, smoking, excess alcohol Consuming 2+ sugar-sweetened beverages per day associated with nearly 2x increased risk Who's Most at Risk Men are more prone than women and have higher mortality rates African American men face a disproportionately higher risk and younger onset Young-onset colorectal cancer is increasingly left-sided and rectal, which can be more life-altering Advances in Treatment Minimally invasive surgery: hospital stays now typically 1–3 days Total neoadjuvant therapy for rectal cancer — organ preservation approach ("watch and wait") to potentially avoid surgery Targeted therapies and immunotherapies showing remarkable response rates for certain genetic profiles (e.g., work from Memorial Sloan Kettering) Early-stage colon cancer has an 85–90% five-year survival rate Key Takeaways Colorectal cancer is largely preventable and highly treatable when caught early. Get screened at 45 — or earlier if you have a family history. Don't ignore symptoms — rectal bleeding and bowel changes deserve prompt evaluation. A colonoscopy is the gold standard: one test, one time, can both find and fix the problem. Treatment today looks nothing like it did for your grandparents' generation. Resources & Next Steps Talk to your primary care physician about scheduling a colonoscopy or Cologuard test Contact Valley Health Surgical Oncology at Winchester Medical Center to learn more about colorectal cancer screening and treatment Learn more at valleyhealthlink.com

This Special Episode on Atrial Fibrillation covers: Cardiology this Week: A concise summary of recent studies Atrial fibrillation burden: clinical relevance of a new outcome Pulsed field ablation: game changer? Drug treatment following atrial fibrillation ablation Spotlight: Holiday Heart Syndrome Host: Rick Grobbee Guests: Rick Grobbee, Konstantinos Koskinas, Jason Andrade, Arian Sultan, Michiel Rienstra Want to watch that special episode? Go to: https://esc365.escardio.org/event/2549 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Jason Andrade, Yasmina Bououdina, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Michiel Rienstra has declared to have potential conflicts of interest to report: consultancy fees from Bayer (OCEANIC-AF national PI) , InCarda Therapeutics (RESTORE-SR national PI), Novartis to the institution. Speaker fee from Daiichi-Sankyo, Pfizer to the institution. Unrestricted research grant from the Dutch Heart Foundation and is conducted in collaboration with and supported by the Dutch CardioVascular Alliance, 01-002-2022-0118 EmbRACE. Unrestricted research grant from ZonMW and the Dutch Heart Foundation; DECISION project 848090001. Unrestricted research grants from the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation; RACE V (CVON 2014–9), RED-CVD (CVON2017-11). Unrestricted research grant from Top Sector Life Sciences & Health to the Dutch Heart Foundation (PPP Allowance; CVON-AI (2018B017). Unrestricted research grant from the European Union's Horizon 2020 research and innovation programme under grant agreement; EHRA-PATHS (945260). This research is funded by the Dutch Heart Foundation and is conducted in collaboration with and supported by the Dutch CardioVascular Alliance, 01 -002 -2022 -0118 EmbRACE.  Emma Svennberg has declared to have potential conflicts

What is the optimal dosing regiment for iron supplements?

Have you ever experienced unexplained fatigue, brain fog, chronic pain, or mysterious symptoms no one can figure out? If so, today's conversation may possibly change everything for you. I am thrilled to have Dr. Neil Nathan join me for a two-part series. Today, in Part 1, we explore mold toxicity, clarify what it is, and explain why it is often overlooked, how to know if it's affecting you, and most importantly, what you can do about it. How to Effectively Address Mold Toxicity Remove yourself from the moldy environment Use binders to target the specific mycotoxins identified in your body Treat mold colonization in your sinuses or gut if necessary Combine an antifungal treatment with agents to break down any protective biofilms Continue with the treatment until your mold toxin levels have decreased and all your symptoms are resolved Bio: Dr. Neil Nathan Neil Nathan, MD has been practicing medicine for over 50 years, and has been Board Certified in Family Practice and Pain Management and is a Founding Diplomate of the American Board of Integrative Holistic Medicine and a Founding Diplomate of ISEAI.  He has written several books, including Healing is Possible: New Hope for Chronic Fatigue, Fibromyalgia, Persistent Pain, and Other Chronic Illnesses and On Hope and Healing: For Those Who Have Fallen Through the Medical Cracks.  He has hosted an internationally syndicated radio program/podcast on Voice America called The Cutting Edge of Health and Wellness Today. He has been working to bring an awareness that mold toxicity is a major contributing factor for patients with chronic illness and lectures internationally on this subject which led to the publication of his ebook, Mold and Mycotoxins: Current Evaluation and Treatment, 2016, (now updated to 2022), and then to his best-selling book Toxic: Heal Your Body from Mold Toxicity, Lyme Disease, Multiple Chemical Sensitivities and Chronic Environmental Illness, (2nd edition just released).  Winter of 2021 he saw the publication of Energetic Diagnosis, a discussion of the value of intuition and energetic devices as an aid to both diagnosis and treatment of medical illness. His book, The Sensitive Patient's Healing Guide, was released in 2024 and the 2nd edition of Toxic is just out in September, 2025.  In this episode: Why mold toxicity is far more common than most people realize How mold toxicity can affect multiple organ systems at the same time How both mold toxicity and Lyme disease can cause widespread, systemic inflammation, and their symptoms can overlap The subtle neurological and mood changes that could show up before a diagnosis How unexplained symptoms are sometimes dismissed  Why modern homes with reduced airflow could increase the risk of mold-related illness How today's toxic environment can stress the liver and kidneys- our organs of detoxification How the concept of mold toxicity has not yet been embraced by conventional medicine  Links and Resources: ⁠⁠⁠⁠⁠Sinus Support Use code BIND to get 10% off ⁠⁠⁠ENVIROBIND ⁠https://yourlongevityblueprint.com/product/glutathione-60-ct/ Guest Social Media Links: Instagram (@askdrnathan)  Website Relative Links for This Show: Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

This week, primary care docs Mark, Kate, Henry and Gary discuss skin lotions to prevent eczema, adding an opioid to ibuprofen for kids with acute injuries, evolocumab (Repatha) for very high risk persons, and 10 year follow-up of antibiotics vs surgery for uncomplicated appendicitis.

Walking With Lyme, Walking With GodSam Sofio carried a simple dream of attending Christian university where faith wasn't an accessory but the air everyone breathed. He pictured chapel worship and professors who prayed before class. He also sensed a calling to tell stories that point people to God.Then his health took a hard turn, and money worries crept in.He woke up bone-tired no matter how long he slept. Headaches throbbed behind his eyes, his joints ached, and his mind stayed foggy. Ordinary days started to feel like hills with no summit, and his dream began to look expensive and impossible.Sam refused to pretend it didn't hurt. He carried his questions to the Lord, sometimes through clenched teeth, and he learned a quiet truth: God never stepped back. In long nights and slow mornings, Sam found the Father near — steady, faithful, and kind.He spent many hours searching for answers. He clicked through articles and forums. He tried to name what was stealing his strength and hope to attend a Christian university. When Lyme disease finally entered the conversation, it brought relief and new complexity at the same time. Treatments took patience, and setbacks took humility. Chronic illness demanded daily courage. Still, God met Sam in his struggles and comforted him so he could comfort others.Little by little, God kept Sam's dream alive. Doors opened, and provision came when it mattered most. Strength arrived in measured portions — enough for the next step. As the fog lifted just enough to see forward, one path came into focus: the Christian campus he had prayed for.That path led him to Cedarville University. The suffering didn't end, yet God kept Sam steady through it. Cedarville became the place where Sam could keep healing, learning, and walking with the Lord.Now, Sam studies professional writing and information design as a junior. He hopes, Lord willing, to serve a Christian nonprofit like Samaritan's Purse after graduating in 2027. He wants to tell on-the-ground stories that help prayer partners and donors see what God is doing.Sam doesn't waste his scars. He advocates for others battling Lyme disease and other chronic illnesses, speaking up so they don't feel invisible, and he's shared his journey in places he never imagined. From a Health and Human Services panel to a conversation with HHS Secretary Robert Kennedy Jr., Sam carries one steady message wherever God sends him: The Lord meets people in suffering, and He stays.https://share.transistor.fm/s/8aeede8bhttps://youtu.be/6y9qK0R8LbY

MRI-guided Focused Ultrasound (FUS) is an FDA-approved treatment option for certain motor symptoms of Parkinson's Disease — particularly medication-refractory tremor and levodopa-induced dyskinesia. But what exactly does it do? And just as importantly — what does it not do? In this episode, I break down: • How MRI-guided Focused Ultrasound works • What part of the brain is targeted • Who may be an appropriate candidate • How it compares to Deep Brain Stimulation (DBS) • The risks, limitations, and realistic expectations Focused ultrasound is not a cure for Parkinson's. It does not slow disease progression. But for carefully selected patients, it can meaningfully reduce specific motor symptoms. As always, this episode is for educational purposes only and is not individual medical advice. Treatment decisions should be made with your neurologist and care team. If you find this helpful, consider subscribing for more evidence-based discussions on Parkinson's treatment options.  Help to support this channel and out efforts to educate the world about Parkinson's Disease and get access to personalized content: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join https://www.patreon.com/pdeducation Please be sure to give support to our channel sponsors: Comfort Linen: https://comfortlinen.com/PARKINSONSDISEASEEDUCATION (15% off entire order when applying the code PARKINSONSDISEASEEDUCATION at checkout) Kizik Shoes: https://kizik.sjv.io/pdeducation Cure Hydration: https://lvnta.com/lv_XG06Rho8SSlXEq3qlV If you have products that you would like for me to review on the channel please send them here: Parkinson's Disease Education P.O. Box 1678 Broken Arrow, OK 74013 Medical Disclaimer All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use. #parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #focusedultrasound #fus

In today's episode, we spoke with Colin Vale, MD. Dr Vale is an assistant professor in the Department of Hematology and Medical Oncology at the Emory University School of Medicine in Atlanta, Georgia.In our exclusive interview, Dr Vale discussed data from a phase 2 trial (NCT03263572) evaluating blinatumomab (Blincyto) plus ponatinib (Iclusig) in patients with Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia. In addition to underscoring the findings and their clinical significance, Vale expanded on how the combination can improve patient quality of life by helping patients avoid procedures like allogeneic stem cell transplant.

Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions

Do your patients feel cared for — or are you just taking care of them? In this episode, Kirk Behrendt interviews Dr. Bryan Laskin, dental author, tech entrepreneur, and patient-advocacy leader, about why dentistry is losing patient trust and what to do about it. You'll learn how private equity and spreadsheet-driven decisions can quietly degrade the patient experience, why “clarity” is the biggest lever for rebuilding trust, and how simple systems and technology can help patients feel listened to, informed, and confident. Listen to Episode 1022 of The Best Practices Show!Main Takeaways:Taking care of people is different than making people feel cared for, and patients primarily feel listened to, communicated with, and given clarity.Private equity has accelerated aggregation in dentistry, and tighter margins can increase the risk of decisions that ignore how patients experience care.Patients may still trust their own dentist, but broader trust in dentists is eroding, making transparency and clarity more important than ever.Building “care more, make more” requires systems that create connection, reinforce clarity, and build confidence to improve recall and referrals.Treatment plans are often accepted at the kitchen table, so practices need to share information that patients can review after leaving the office.Removing human variability by automating “robotic” tasks frees the team to do what humans do best: welcome, connect, and care.When evaluating technology, the first question should be how it makes people feel, because patient experience drives growth.Snippets:00:00 Huge difference between taking care of people and making people feel cared for.00:03 Bryan's background: practice ownership, CAD/CAM training, scaling a patient engagement solution, and standards work.00:05 “Care more, make more” and the clarity, confidence, connection framework.00:06 Why dentistry's recurring hygiene model attracted private equity and accelerated DSO growth.00:09 What spreadsheets miss: the patient experience and the “silent killer” of lost confidence.00:10 “Patients still trust their dentist, but patients don't trust dentists.”00:14 The biggest problem: patients are confused, and confusion destroys confidence.00:16 Transparency as the flip side of trust and why everyone “Googles” their care.00:22 New patient intake as a systems problem and how automation improves the human welcome.00:25 The pathway to trust: connection, clarity, then confidence.00:31 The technology question: “How does it make people feel?”00:32 Where to learn more: cair.net, toothapps.com, and Bryan's books.Guest Bio/Guest Resources:Dr. Bryan Laskin has spent over two decades at the intersection of healthcare, technology, and patient advocacy. As a practicing dentist, he witnessed firsthand the artificial barriers separating dental and medical care despite their profound connections. As a healthcare technology entrepreneur, he's developed innovative solutions to improve care coordination, enhance patient communication, and increase healthcare transparency.Resources mentioned:Cair (patient-facing): https://cair.net/ToothApps (practice side): https://www.toothapps.com/Brian's website: https://bryanlaskin.com/Books: The Patient First Manifesto https://bryanlaskin.com/patient-first-manifestoMore Helpful Links for a Better Practice & a Better Life:The Best Practices Show: https://www.actdental.com/podcast/Best Practices Association: https://www.actdental.com/bpaUpcoming Events & Workshops: https://www.actdental.com/events/Smile Source: https://www.smilesource.com/Subscribe on Apple Podcasts: https://podcasts.apple.comSubscribe on Spotify: https://open.spotify.com

On this week's Tech Nation, Moira speaks with Dr. Adam Rogers of NervGen Pharma about a new treatment in development that's seeing significant trial results for patients with spinal cord injuries. Then, does that look on your pet's face mean what you think it means? Jay Ingram joins Moira to talk about “The Science of Pets” and what it has to do with humans.On this week's BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that's showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, trial participants are seeing increased function as much as 10 years post-trauma.

NMIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Janet Kukreja, MD, MPH, FACS CME Available: https://cme.auanet.org/URL/GUPOD253 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: AstraZeneca Johnson & Johnson LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Select and implement immunotherapy regimens for patients with NMIBC in accordance with current AUA Guideline recommendations, tailoring treatment choices to tumor characteristics and individual patient needs. 2. Incorporate FDA-approved gene therapy options into NMIBC management by aligning therapeutic approaches with patient-specific factors, disease risk profile, and evolving clinical evidence. 3. Develop and integrate practical strategies to anticipate, monitor, and manage treatment-related side effects and immune-related adverse events in NMIBC, ensuring patient safety and treatment continuity.

Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions

In this episode, I discuss the importance of being a truth teller to your clients, which produces better results for them and gains you the highest level of respect!--------We just launched our new, free soft tissue injury evaluation and treatment training, The Peak Injury Treatment Method.It is the first step in learning how to cut your treatment times in half and easily double your income so you can avoid burnout and help more people get out of pain!If you want to download the training for free, with no strings attached, just click the link below ⬇️⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click Here To Download Free Training⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Please consider joining our 'Soft Tissue Treatment Revolution' community on Facebook, where it's much easier to engage as a group. It's an awesome group on Facebook, covering topics in Injury Evaluation, Treatment, Client Communication, Practice Marketing, Increasing Sales, Scaling Business, and a few other topics of interest in the Soft Tissue Injury Space.As always if you want to be part of the soft tissue revolution here's what you need to do:1. Visit our Facebook Group Page by clicking here

What if I told you that one of the most popular beauty treatments today is made form one of the most powerful toxins known to science?In this bonus episode, I'm breaking down what Botox actually is, how it went from food poisoning to a cosmetic staple, and why it's become so normalized that people are getting it down on their lunch breaks. We'll talk about how it works in the body, the side effects people don't always mention, and what repeated use might actually be doing long-term.This isn't about fear or judgment - it's about understanding what's really going on beneath the surface. Because when something this powerful becomes routine, it's worth asking a few questions.Are. You. Ready?****************Sources & Further Reading:Medical Background on Botulinum ToxinSimpson, L. L. — “The Origin, Structure, and Pharmacological Activity of Botulinum Toxin.” Pharmacological ReviewsArnon, S. S. et al. — “Botulinum Toxin as a Biological Weapon: Medical and Public Health Management.” Journal of the American Medical Association (JAMA)Nigam, P. & Nigam, A. — “Botulinum Toxin.” Indian Journal of DermatologyHistory of BotoxFrank J. Erbguth — “Historical Notes on Botulism, Clostridium botulinum, Botulinum Toxin, and the Idea of the Therapeutic Use of the Toxin.” Movement DisordersHow Botox Works & Medical UseMayo Clinic — “Botox Injections: Overview, Uses, and Risks”American Academy of Dermatology — “Botulinum Toxin Therapy”Carruthers, J. & Carruthers, A. — “Botulinum Toxin Type A in the Treatment of Glabellar Rhytides.” Dermatologic SurgerySide Effects & Safety ConsiderationsU.S. Food and Drug Administration — Botox Medication Guide and Safety LabelingAmerican Academy of Dermatology — Clinical Guidance on Botulinum Toxin UseMayo Clinic — Risks and complications of Botox injectionsLong-Term Effects & Muscle ChangesDurand, P. D. et al. — “Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect.” Aesthetic Surgery JournalMathevon, L. et al. — Research on structural muscle changes after botulinum toxin injectionSchroeder, A. S. et al. — “Muscle Biopsy Evidence of Long-Term Changes After Botulinum Toxin Injection”Resistance & ImmunogenicityBenecke, R. — “Clinical Relevance of Botulinum Toxin Immunogenicity”Bellows, S. et al. — Research on antibody formation after repeated botulinum toxin exposureStephan, F. et al. — Studies on resistance to botulinum toxin therapyCosmetic Industry & Botox TrendsAmerican Society of Plastic Surgeons — Plastic Surgery Statistics ReportMeredith Jones — Skintight: An Anatomy of Cosmetic Surgery****************Leave Us a 5* Rating, it helps the show!Apple Podcast:https://podcasts.apple.com/us/podcast/beauty-unlocked-the-podcast/id1522636282Spotify Podcast:https://open.spotify.com/show/37MLxC8eRob1D0ZcgcCorA****************Follow Us on Social Media & Subscribe to our YouTube Channel!TikTok:tiktok.com/@beautyunlockedthepodYouTube:@beautyunlockedspodcasthour****************INTRO/OUTRO MUSIC:FASION/ '1-800-DIRTY'/Courtesy of Epidemic Soundwww.epidemicsound.com

Stimulant medication has been widely prescribed to treat ADHD effectively for decades. But is the impact for a person more than just greater focus and attention? Does it change a person's understanding of oneself, one's relationships, and overall approach to life--i.e. one's personality? Listen to our open discussion of this question with the LGP team and our guest, psychiatrist and Stanford professor, Dr. John Leikauf.Hosts: Eyrn, Al, ToshiaGuest: John E. Leikauf, MDResourcesFantozzi P, Muratori P, Caponi MC, Levantini V, Nardoni C, Pfanner C, Ricci F, Sesso G, Tacchi A, Milone A, Masi G. Treatment with Methylphenidate Improves Affective but Not Cognitive Empathy in Youths with Attention-Deficit/Hyperactivity Disorder. Children (Basel). 2021 Jul 14;8(7):596. doi: 10.3390/children8070596. PMID: 34356575; PMCID: PMC8307630.Kirkpatrick MG, Johanson CE, de Wit H. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar;27(3):256-64. doi: 10.1177/0269881112472564. Epub 2013 Jan 23. PMID: 23343596; PMCID: PMC4241296.Leikauf, John E., et al. "Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine." Journal of the American Academy of Child & Adolescent Psychiatry, 2025, https://doi.org/10.1016/j.jaac.2025.07.007.Maoz H, Gvirts HZ, Sheffer M, Bloch Y. Theory of Mind and Empathy in Children With ADHD. J Atten Disord. 2019 Sep;23(11):1331-1338. doi: 10.1177/1087054717710766. Epub 2017 May 30. PMID: 28558473.Takım U, Belli H, Gökçay H, Köse H, Arslan Akgül H, Çakır A. Examination of Changes in Levels of Empathy and Narcissistic Pathology After Treatment of Adult with Attention-Deficit/Hyperactivity Disorder. Alpha Psychiatry. 2024 Sep 1;25(5):598-603. doi: 10.5152/alphapsychiatry.2024.241630. PMID: 39553487; PMCID: PMC11562234.

In this segment Evan and Guru talk about Steve Kerr and his treatment of Podziemski vs other players and speak on the 49ers and Aiyuks relationship!

352: Got asthma or know someone who does? What about POCD? Lung issues? Today I'm sharing the top foods that help reduce mucus in the lungs (and the top ones that do!).  Topics Discussed:→ What foods reduce lung mucus? → What foods increase mucus? → Best diet for asthma? → How to clear lung mucus? → Foods that support lung health? As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Kasandrinos | Go to https://www.kasandrinos.com/digest and use code DIGEST for 25% off → Pique Life | https://piquelife.com/digest for up to 20% OFF and a free starter kit  Timestamps: → 00:00:00 - Introduction  → 00:02:47 - Foods that cause mucus in lungs  → 00:09:09 - Mucus eliminating foods  Further Listening: → Dave Asprey Shares About His Face Lift, Long COVID Treatment, The Truth About Peanuts + Nutrition → There's a Ball of Mold In My Lungs (pt. 1) The Severity, The Treatment, How Long I've Had it Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

When Emily's twin, Amelia, ended up in the hospital twice, she knew that stress wasn't something to be dismissed as “all in your head”. First of all, the head is connected to the body (by the neck), so stress is a physical issue that you can feel and be hurt by in all sorts of ways. Too much stress, at work, at home, in life, and you can run up against a real burnout situation. And it can wreak havoc on you mental health and physical health. The Nagoski twins are the authors of Burnout: The Secret to Unlocking the Stress Cycle and Emily joins us to talk about how our stress response instincts aren't that different than a zebra's when faced with a lion. The difference? A zebra knows how to complete a stress cycle and return to normal, whereas we're likely to hold on to work worries, relationship concerns, or other stresses around the clock, pursued by the lion constantly. Emily has advice on how to complete those cycles, get to a better place, and fight burnout. A big part of that is what she calls “bubbles of love”. Not a sex thing. Thank you to all our listeners who support the show as monthly members of Maximum Fun. Check out our I'm Glad You're Here and Depresh Mode merchandise at the brand new merch website MaxFunStore.com! Hey, remember, you're part of Depresh Mode and we want to hear what you want to hear about. What guests and issues would you like to have covered in a future episode? Write us at depreshmode@maximumfun.org. Depresh Mode is on BlueSky, Instagram, Substack, and you can join our Preshies Facebook group.  Help is available right away. The National Suicide Prevention Lifeline: 988 or 1-800-273-8255, 1-800-273-TALK Crisis Text Line: Text HOME to 741741. International suicide hotline numbers available here: https://www.opencounseling.com/suicide-hotlines

Every year, thousands of people pursue cosmetic procedures hoping to look refreshed, confident, and natural—but too many end up with results they never expected. So how do you avoid becoming one of the “botched” stories you see online? In this episode of The Doctor Youn Show, Dr. Anthony Youn pulls back the curtain on the biggest mistakes people make before cosmetic procedures—and how to avoid them. From Botox and fillers to facelifts, breast surgery, liposuction, and laser treatments, he shares the insider advice every patient should know before stepping into a clinic. Dr. Youn explains why smoking dramatically increases your risk of complications, how trendy procedures like deep plane facelifts can be misunderstood, and the red flags that may signal a provider isn't the right choice. If you're considering any type of cosmetic treatment—or simply want to make sure you're doing it safely—this episode will help you understand the risks, ask the right questions, and choose the right surgeon so you can achieve results that look natural, healthy, and beautifully you.

In this episode, we break down a major factor in treating SIBO and preventing recurrence: biofilm disruption. You'll learn how to identify the telltale signs of biofilms, the steps to our proven treatment protocol, and discover the dietary and supplement strategies that support lasting gut recovery. Our approach is backed by our recently published study, Biofilm Disruption Enhances Antimicrobial Therapy for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth. Read the full findings here:https://pubmed.ncbi.nlm.nih.gov/41394228/.    If you've struggled with recurring SIBO and felt like nothing works, this episode will guide you to effective solutions.  

What starts with airport chaos and accessibility frustrations turns into a meaningful conversation about what it really takes to move rare disease research forward.Sean and Kyle kick things off with travel stories from their trip to Rare At Sea, including misplaced mobility equipment, inaccessible hotel setups, and the all-too-common surprises that come with traveling disabled. Then they're joined by Derek Ansel, who pulls back the curtain on the world of clinical research—breaking down what CROs do, why diagnosis matters so much, and how patients, providers, and industry all play a role in bringing treatments closer to reality.It's equal parts relatable, informative, and encouraging—mixing everyday disability experiences with a behind-the-scenes look at the systems, strategy, and people helping drive progress in rare disease.

Today's guest shares the events leading up to her postpartum psychosis, what she experienced, and how she managed to recover. It is important to hear stories like this so people understand postpartum psychosis and know how to get help. We all need to recognize the symptoms and get the people we love the help they need. Join us for Jade's powerful story.  Jade Lloyd is a survivor of postpartum psychosis and a maternal mental health advocate from the UK. Her maternal mental health struggles began with anxiety and sleeplessness, soon progressing to scary, intrusive thoughts and hallucinations. Jade shares her story in the hope that more knowledge and understanding about postpartum depression, anxiety, and psychosis will lead to more moms getting the help they need without shame, blame, and stigma.  Show Highlights: Jade's story: An easy pregnancy and plans for an at-home water birth turned into an induction, epidural, followed by a ventouse/forceps delivery. Immediate feelings of shame and failure for not having the delivery she wanted With a December 2020 birth, COVID lockdowns contributed to Jade's mental health struggles. The first symptom Jade noticed was anxiety. Social media was Jade's primary socialization, which led her to feel even more inadequate as a new mom. Getting up the courage to admit to the doctor that she was “not ok.” When asking for help makes you feel like an inconvenience A specific event one night that scared Jade because of intrusive thoughts of harming herself Dealing with the self-imposed pressure to be the perfect mom Help from medications and a doctor who checked in with Jade regularly Even with medication, Jade's struggles continued with intrusive thoughts.  Jade's feelings of losing touch with reality and experiencing hallucinations Treatment in the mother-baby unit Jade's passion for sharing her story and doing advocacy work for those with PPP Hope for the future Jade's message to listeners and those who are suffering: “It's okay to ask for help.” Resources:  Connect with Jade Lloyd: Instagram  Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visitcdph.ca.gov. Please find resources in English and Spanish at Postpartum Support International, or by phone/text at 1-800-944-4773.  There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services. You can also follow PSI on social media: Instagram, Facebook, and most other platforms. Visit www.postpartum.net/professionals/certificate-trainings/for information on the grief course.  Visit my website, www.wellmindperinatal.com, for more information, resources, and courses you can take today!  If you are a California resident seeking a therapist in perinatal mental health, please email me about openings for private pay clients. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Jonathan Dickinson, CEO and Co-Founder of Ambio Life Sciences, about the evolving role of ibogaine in psychedelic medicine. Listen to the full episode: https://thethirdwave.co/podcast/episode-347/?ref=278 Jonathan shares his path from leading the Global Ibogaine Therapy Alliance to helping build one of the field's most prominent ibogaine treatment organizations. Together they explore ibogaine's expanding therapeutic potential for traumatic brain injury, addiction, and neurological conditions, along with the clinical realities of delivering this powerful medicine safely. They also discuss the challenges of scaling ibogaine treatment, the importance of preparation and integration, and how traditional Bwiti knowledge from Gabon continues to shape ethical and culturally grounded approaches to this work. Jonathan Dickinson is the CEO and Co-Founder of Ambio Life Sciences and a leading expert on ibogaine therapy. With more than 15 years of experience in psychedelic research, clinical care, and traditional practice, he has helped shape global safety standards for ibogaine treatment. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, Jonathan has published research on ibogaine's therapeutic potential for trauma, traumatic brain injury, and neurological conditions. He has also been initiated into the Bwiti traditions of Gabon and holds a Nagoya-compliant export license for Tabernanthe iboga root. Highlights: Jonathan Dickinson's path from the Global Ibogaine Therapy Alliance to Ambio Life Sciences How ibogaine treatment expanded beyond opioid detox The growing use of ibogaine for traumatic brain injury and veterans' recovery Why ibogaine treatment requires extensive medical screening and preparation The importance of integration and community support after treatment What Bwiti traditions in Gabon teach about working with iboga The challenges of scaling ibogaine treatment safely Why ibogaine may create a longer window for lasting change

In this first part of what became a two-part conversation, we sat down with anesthesia provider Charles Miller from Scenic City Neurotherapy for a discussion that challenged so many assumptions about ketamine therapy.Charles presents what he calls the "collective lie" in ketamine therapy - the argument that the obsession with psychedelic experiences and mystical insights for a growing segment of providers in our industry is not just misguided, but actually making our patients worse. He walks through the neurobiological evidence showing that the real therapeutic action happens days after treatment during the neuroplasticity window, not during those profound moments when patients feel like they're talking to God or having life-changing realizations.You'll hear Charles critique the research methodologies that seem to support ketamine-assisted psychotherapy, explaining why group averages can mask poor individual outcomes and why the frequently cited KAP studies may actually show lower success rates than standard ketamine protocols. He also shares refreshingly honest advice about starting a clinic - including his decision to open with folding chairs rather than go into debt for impressive furniture.We're also trying something new with this episode: audio sidebars. As we talk, we'll pause to provide additional context about complex concepts like psychoplastogens, research study limitations, and the cutting-edge science behind separating therapeutic effects from psychedelic experiences. Think of these as educational moments designed to help you fully understand and enjoy the episode.This conversation will make you question whether the approaches many of us have been using actually serve our patients - or if we've been chasing the wrong mechanisms entirely.What You'll Learn in This Episode· Charles's entrepreneurial journey - How he started Scenic City Neurotherapy with minimal capital and his advice for keeping overhead low during startup· The "collective lie" concept - Why Charles believes the field's emphasis on ketamine experiences actually reduces treatment success rates· Neuroplasticity mechanisms - Detailed explanation of the NMDA-glutamate-BDNF pathway and why the therapeutic window occurs after, not during, ketamine administration· Psychoplastogens vs psychedelics - Understanding David E. Olson's groundbreaking research on compounds that promote neuroplasticity without hallucinogenic effects· Research methodology critique - Analysis of popular KAP studies and why methodological flaws may be masking poor individual patient outcomes· Evidence-based positioning - How to counter the "ketamine is just anesthesia" criticism with solid neurobiological science· Experience vs neuroplasticity - Why Charles argues that focusing on insights and visions during treatment may be counterproductiveKey Takeaways· Ketamine may function primarily as a psychoplastogen rather than a classic psychedelic, blocking NMDA receptors to trigger neuroplasticity cascades instead of flooding serotonin receptors like traditional psychedelics· The therapeutic neuroplasticity window occur days to weeks after ketamine administration, when BDNF-driven synaptic remodeling takes place, not necessarily during the acute dissociative experience· Research comparing ketamine-assisted psychotherapy to standard protocols could show mixed results, with some studies reporting lower individual response rates despite promising group averages· Providers who overfocus on experiential components during treatment may inadvertently create performance pressure that could reduce patient outcomes and increase perceived treatment failure rates· Startup ketamine clinics might benefit from beginning embarrassingly small with minimal overhead, focusing resources on essential clinical equipment rather than impressive lobbies or furniture· David E. Olson's psychoplastogen research suggests that neuroplastic benefits might be separable from psychedelic experiences, supporting approaches that prioritize physiological mechanisms over experiential componentsEpisode 52 show notes:00:00:00 - Teaser: When Patients Feel They Failed00:00:17 - Introduction and Episode Setup00:02:06 - Charles's Journey into Ketamine Therapy00:04:30 - The Entrepreneurial Leap00:06:00 - Startup Advice: Think Embarrassingly Small00:08:30 - Evolution of the Ketamine Field00:10:00 - The "Collective Lie" Concept Introduction00:12:30 - Neurobiological Mechanisms00:16:30 - Psychoplastogens vs. Psychedelics00:24:00 - David E. Olson's Revolutionary Research00:27:27 - Audio Sidebar: Psychoplastogens & David E. Olson00:30:00 - Research Critique: KAP Study vs Real-World IV Ketamine Data00:34:27 - Episode Wrap-upThanks for listening

AP Washington correspondent Sagar Meghani reports on the White House chief of staff facing an early stage breast cancer diagnosis.

In this episode, the hosts unpack the controversial exit of Vinay Prasad from the FDA and what it reveals about fractures inside the MAHA coalition and the broader Trump-era health policy landscape. They examine the disputes surrounding rare-disease drug approvals—particularly Huntington's gene therapy—alongside ongoing battles over COVID vaccines, regulatory standards, and public trust in federal health agencies. The discussion also explores how political alliances, pandemic-era commentary, and conflicts with patient advocacy groups ultimately contributed to Prasad's downfall and what it may signal for the future of vaccine policy and biomedical regulation in the U.S. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

Bonus episode! I had the opportunity to talk to the folks at Dexcom about their presentations at ATTD and I wanted to bring you the interview sooner rather than later. ATTD is the Advanced Technology and Treatments for Diabetes conference, this year it took place in Barcelona. If you're new around here, there are a few big diabetes conferences where studies are presented and news is made. ATTD in spring, ADA and ADCES in summer and a few more scattered here and there. We'll be sharing more from ATTD in upcoming interviews with other tech companies. But today I'm talking to Jessica Castle, VP of Medical Affairs at Dexcom – she's also an adult endocrinologist with a lot of clinical trial experience. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

I dive into the taboo topic of pornography and violent porn addiction, citing two studies that are having great results in cessation and reduction viewing of the behavior. I discuss how it impacts people's lives and the church. It's time to bring this topic out into the light for genuine healing and transformation.

Medical Notes: A New Low-Calorie Sugar, The Neurological Differences Of Autism, And How To Tell If Your Cancer Treatment Is Working Are autistic brains structurally different? Is ‘keto' the key to a more resilient brain? A test that can speed up decision-making in cancer treatment. Good news for sugar addicts! Host: Maayan Voss de Bettancourt  Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. David Puder is joined by forensic psychiatrist Dr. Michael Cummings, who has spent his career at the world's largest forensic state hospital, and child psychiatrist Dr. Blaire Heath, to examine how fixed false beliefs, or delusions, can lead to aggression and violence. Each guest brings their expertise to discuss the major delusion types most associated with harm in forensic settings, including persecutory, Capgras (impostor syndrome involving loved ones), Cotard's ("I am dead"), erotomanic, jealous (Othello syndrome), somatic, and referential delusions.  The episode covers practical clinical tools, including the Simple Delusional Syndrome Scale and Brown Assessment of Beliefs Scale, the role of clozapine in reducing violence risk, and the use of cognitive behavioral therapy to create psychological "escape routes" by treating delusions as testable hypotheses. Modern risks are also addressed, including how AI chatbots and algorithms can reinforce and amplify delusional thinking and contribute to emerging cases of AI-related psychosis.  By listening to this episode, you can earn 1.5 Psychiatry CME Credits. Link to blog Link to YouTube video

The Nurses Report on America Out Loud with Ashley Caputo, RN, FMP – Ashley Caputo explores growing interest in alternative cancer therapies, including repurposed medications, immune-supportive compounds, and metabolic approaches. The discussion examines patient demand for options beyond conventional oncology while highlighting debate around emerging research, medical freedom, and evolving perspectives in cancer care...

Gabriela Rosa, DrPH (Candidate, Harvard), is a Harvard-awarded fertility specialist, founder of The Rosa Institute, and author of Fertility Breakthrough: Overcoming Infertility and Recurrent Miscarriage When Other Treatments Have Failed. She pioneered telehealth-based, integrative fertility care, making evidence-based solutions accessible worldwide. Gabriela also created and hosts The Fertility Challenge, a free online program that reaches tens of thousands globally each year. Her F.E.R.T.I.L.E. Method® has supported more than 204,000 people across 111 countries, with published research demonstrating a 78.8% live birth rate among patients in her signature program—even after years of infertility, recurrent miscarriage, and failed treatments. In this episode, Dr. Gabriela Rosa exposes why standard fertility pathways and IVF-first strategies miss root causes—like incomplete diagnostics, lifestyle, and environmental drivers—and explains how deeper, integrative work dramatically improves live birth outcomes.   RESOURCES: Learn more about Dr. Gabriela Rosa here: https://fertilitybreakthrough.com/ Instagram: @dr.gabrielarosa Get her Fertility Breakthrough book here: https://fertilitybreakthrough.com/resources-shop/fertility-breakthrough-overcoming-infertility-and-recurrent-miscarriage-when-other-treatments-have-failed/ Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 00:00 – Intro ​01:49 – Sponsor: Peluva barefoot shoes ​03:35 – Dr. Gabriela's journey and Harvard research validation ​09:00 – 20 failed IVF cycles, "unexplained" infertility, and what IVF stats hide ​15:59 – Why standard fertility workups are so limited (only four tests) ​27:40 – Real root causes: lifestyle, environment, and upstream fertility factors ​38:36 – Treating fertility as a team sport and looking far upstream in both partners ​43:49 – Broken lab testing: insulin, glucose tolerance, and lazy "unexplained" labels ​45:21 – Common hidden issues: thyroid, insulin resistance, and missed diagnoses ​52:30 – Success stories, and where to find Dr. Gabriela's work    WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

Episode Notes Complicated UTIs just got a whole lot less complicated—or did they? Dr. Dana Bowers and Kyle Molina (@kcmolinaID) join Dr. Whitney Buckel to break down what's new, what's controversial, and what this means for your day‑to‑day antimicrobial decisions. Join us as we dig into the biggest updates, the evidence behind them, and the clinical pearls you won't want to miss. References: Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495. Trautner BW, Cortes-Penfield NW, Gupta K, et al. Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management. Published July 17, 2025. https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/ Kadry N, Natarajan M, Bein E, Kim P, Farley J. Discordant Clinical and Microbiological Outcomes Are Associated With Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections. Clin Infect Dis 2023;76(10:1768-1775. https://academic.oup.com/cid/article/76/10/1768/6980780 USCAST Oral cephalosporin STIC against S. aureus and E. coli meeting recording. https://www.youtube.com/watch?v=HieaVFAC08s MacDougall C. A Cloudy Crystal Ball: Critically Assessing and Rethinking the Antibiogram. Clin Infect Dis. 2023;77(11):1501-1503. doi:10.1093/cid/ciad468 Koehl J, Spolsdoff D, Negaard B, et al. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025;85(3):240-248. doi:10.1016/j.annemergmed.2024.10.013 Dunne MW, Aronin SI, Das AF, et al. Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial. Clin Infect Dis. 2023;76(1):78-88. doi:10.1093/cid/ciac704 Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) or @breakpointspodcast_sidp (https://www.instagram.com/breakpointspodcast_sidp/)https://www.instagram.com/breakpointspodcast_sidp/?hl=en Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/ SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: https://sidp.org/Become-a-Member Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/

My website My Instagram

Join Rebecca Johnson as she discusses reversing MS symptoms through the carnivore diet and natural healing after rejecting conventional paths to live off-grid in Spain. A story of radical healing.Join the Kiltz Mighty Tribe Community - it's free: https://kiltz-mighty-tribe.mn.co/Join us for our next Kiltz Health meatups: Albany Meatup 5/30: https://kiltzmeatup.com/Chicago Meatup 7/25: https://kiltzmeatup.com/Need help on your Keto and Carnivore Journey? Sign up for a $39 Intro call with one of our Kiltz Health Coaches: https://calendly.com/d/cxdf-5ft-z2k/kiltz-health-one-on-one-coaching

"Our goal of precision oncology has been to shift to tailored therapies that can help to improve treatment efficacy and ultimately improve patient outcomes. Resistance biomarker testing can help the care team to detect these genomic changes that the tumor may have acquired during therapy that makes the cells resistant to therapy. This information can be extremely helpful when we're talking about making choices about second-line or subsequent-line therapy," ONS member Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP®, advanced practice RN at the University of Texas MD Anderson Cancer Center in Houston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about drug resistance biomarker testing. This podcast episode is sponsored by AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes  This episode is not eligible for NCPD credit.  ONS Podcast™ episodes: Episode 389: Biomarker Testing for Non-Small Cell Lung Cancer Episode 373: Biomarker Testing in Prostate Cancer Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies ONS Voice articles: Help Your Patients Understand Biomarker Resistance Testing Key Patient Education Points for Biomarker Resistance Testing Quick Quiz: How Much Do You Know About Drug Resistance in Cancer? Quick Quiz: How Much Do You Know About Somatic Biomarker Resistance Testing? When Targeted Therapy Stops Working, What's Next? Discover How Biomarker Resistance Testing Opens New Doors ONS Biomarker Database Clinical Journal of Oncology Nursing article: Tumor-Agnostic Therapies Reshaping Cancer Care ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology ONS Genomics and Precision Oncology Learning Library American Cancer Society Cancer Action Network: Access to Biomarker Testing page White paper: The Landscape of Biomarker Testing Coverage in the United States Find out which states are currently discussing biomarker testing bills and how you can advocate for them through ONS. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We know that biomarkers are playing an ever more important role in cancer care, and really, their use can range anywhere from helping us to confirm a given diagnosis, understand a patient's cancer susceptibility or risk, evaluate prognosis, as well as personalize treatment recommendations. … But in some cases, though, biomarkers can also help us to avoid therapies that are not likely to work. We also call these drug resistance biomarkers. These are those biomarkers that signify that a tumor is unlikely to respond to a given therapy." TS 1:50 "Resistance to cancer therapies is one of the most common issues that arises during cancer treatment. Because the populations of cancer cells within a tumor can be very diverse, when a given drug kills the cells that are sensitive to that therapy, it can also eventually leave behind resistant tumor cells, which can grow and multiply over time. So this can ultimately lead to a point where the treatment that was initially effective is no longer able to control the disease." TS 4:33 "While costs have come down, there can still be a cost associated with biomarker testing, and in some cases, this can be considered a barrier to care. What patients pay out of pocket can vary widely depending on their insurance coverage. So we have some data that was published from the American Cancer Society Cancer Action Network, and this was published a few years ago in 2023, which showed the average allowed unit cost to insurers per biomarker test ranged anywhere from about $79 for patients who were on Medicaid to about $224 for large-group, self-insured patients." TS 10:03 "There's research underway that's looking not only at genomic changes—so DNA changes that impact drug resistance—but how other substances such as RNA and proteins within the cell can also contribute to drug resistance. And this kind of falls into not just genomics but multiomics field. I have no doubt whatsoever that the use of artificial intelligence and machine learning is likely going to play a large role in drug resistance research. And really, these tools can help researchers to analyze complex data sets, identify novel resistance biomarkers, predict resistance patterns, as well as help to develop treatments that may overcome some of those resistance mechanisms." TS 17:00

The Nurses Report on America Out Loud with Ashley Caputo, RN, FMP – Ashley Caputo explores growing interest in alternative cancer therapies, including repurposed medications, immune-supportive compounds, and metabolic approaches. The discussion examines patient demand for options beyond conventional oncology while highlighting debate around emerging research, medical freedom, and evolving perspectives in cancer care...

In this episode, Dr. Rena Malik, MD sits down with Dr. Irwin Goldstein, a pioneer in sexual medicine, to unravel the complexities of orgasm, erectile dysfunction, and the impact of common medications on sexual health. They explore cutting-edge research on orgasm phases, discuss medication-induced sexual dysfunction, and highlight practical solutions and therapies for both men and women. Listeners will walk away with actionable knowledge about optimizing sexual health, understanding new treatment options, and the importance of seeking expert care for sexual concerns. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00:00 Introduction00:02:48 Phases of orgasm00:10:25 Differences in orgasm disorders00:18:06 Treatments and therapies00:30:54 Medication-induced sexual dysfunction00:42:18 Erectile dysfunction causes00:51:59 Hard flaccid syndrome01:03:48 Shockwave and PRP therapy01:13:34 Female sexual function misconceptions01:21:00 Hormonal birth control effects01:28:34 Long-term use of ED medications Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

Josh Thomson discusses his time at CPI. Follow Josh on X/Instagram @therealpunk

Health and Human Services Secretary Robert F. Kennedy Jr. had another tough week. In addition to Kennedy having surgery on a torn rotator cuff, the nomination of his ally to become surgeon general is teetering in the Senate, the controversial head of the Food and Drug Administration's vaccine center is resigning next month, and a new survey shows Americans trust government health officials less than they do former Biden official Anthony Fauci. Meanwhile, the Trump administration's fraud crackdown is reaching private Medicare insurance plans. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News' Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Andy Schneider of Georgetown University about the Trump administration's crackdown on Medicaid fraud in Democratic-led states.  Visit our website for a transcript of this episode.Plus, for "extra credit" the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: The Marshall Project's "The Harrowing Journey Home for Families Leaving Immigration Detention," by Shannon Heffernan, Jesse Bogan, and Anna Flagg.  Anna Edney: The Wall Street Journal's "The Boom in Autism Therapy Is Medicaid's Fastest-Growing Jackpot," by Christopher Weaver, Tom McGinty, and Anna Wilde Mathews.  Shefali Luthra: The New York Times' "States Move To Limit Access to H.I.V. Treatment," by Apoorva Mandavilli.  Joanne Kenen: The Idaho Capital Sun's "988 Ended His Call. Now an Idaho Teen Is Pushing for a Fix to State's Parental Consent Law," by Laura Guido.  

ABOUT THE EPISODE:Tough love. Two words that get thrown around constantly in the addiction world, and yet nobody can quite agree on what they mean. Kick them out. Cut them off. Save yourself. That's the version I heard early on, and I couldn't do it. Not because I was too soft, but because something about it felt fundamentally wrong - especially with a teenager.In this episode, Cathy and I get practical on the topic of this illusive thing called “tough love.” We walk through the nine actual actions we took with our own kids, in order, from the very first steps all the way to the hardest ones (ones we call “strong love”) as a way of demonstrating action, not theories. Just two moms who were figuring it out as we went, without the language, community or support we needed at the time.YOU'LL LEARN:What Dr. Gabor Maté said about tough love that stopped me coldWhy I stopped using the phrase “tough love” and what I call it insteadNine “strong love” actions Cathy and I took with our own kids, and what we wish we had done differentlyThe thing every person in recovery has told me about what finally changed things for themThe two books I recommend to every parent, no matter where you are in thisEPISODE RESOURCES:Heather Hayes on Hopestream episode 111Mary Crocker Cook on Hopestream episode 223Jessica Lahey on Hopestream episode 163Trish Ruggles on Hopestream episode 313Safe Enough To Change course in Hopestream Community's Limited MembershipThis podcast is part of a nonprofit called Hopestream CommunityGet our free, 4-video course, Hope Starts Here, and access to our Limited Membership hereLearn about The Stream, our private online community for momsFind us on Instagram hereWatch the podcast on YouTube hereDownload a free e-book, Worried Sick: A Compassionate Guide For Parents When Your Teen or Young Adult Child Misuses Drugs and AlcoholHopestream Community is a registered 501(c)3 nonprofit organization and an Amazon Associate. We may make a small commission if you purchase from our links.

PREVIEW FOR LATER. Alan Tonelson discusses the ongoing threat of fentanyl trafficking from China. While U.S. overdose deaths have declined due to improved treatment, experts suggest the flow of illicit substances remains largely unchanged. (5)1903